Sangdi Wang

Sangdi has a B.Sc. in Pharmaceutical Engineering (Chongqing University of Technology, China) and an M.S degree in Pharmaceutical Analysis (Queen’s University Belfast, United Kingdom). He is completing his Ph.D thesis in Ocular Drug Delivery. Sangdi has research experience in developing in situ forming implants formulations as ocular delivery systems for the sustained release of biologics to the posterior segment of the eye and extensive knowledge in protein analysis and characterisation techniques, including high-performance liquid chromatography (HPLC), spectrophotometry, thermal analysis, imaging techniques and biological assays.